Categories
Latest Industry Intelligence
Precision medicine uses information about an individual’s genes, proteins, and environment to prevent, diagnose, and [...]
In January 2022, DDW’s Megan Thomas spoke to decision-makers from the drug discovery industry about [...]
2022 was a complicated year. Global challenges like the Ukraine war and the continued impact of Covid-19 have been felt across the world. And yet it was also a year of incredible innovation in drug discovery, with the potential of new biotechnology beginning to be revealed. Our top 10 most popular online articles for 2022 […]
Evonik has launched a non-animal-derived squalene suitable for vaccines and other pharmaceutical applications. PhytoSquene is the first known amaranth oil-derived squalene on the market for use in adjuvants in parenteral dosage forms. It is an alternative to animal-derived squalene, which for pharmaceutical applications is typically sourced from shark liver oil. “It is alarming that biodiversity […]
When he was 17 years old, Joe Landolina created a revolutionary gel. Now, he is 29 years old and co-founder and CEO of Cresilon, his homegrown Brooklyn-based biotech company that recently submitted the gel for FDA 510(k) clearance for human use and raised $38.5 million in Series A3 financing last year. DDW’s Megan Thomas caught […]
Results from the Phase III placebo-controlled efficacy study of Medicago’s plant-based Covid-19 vaccine candidate in combination with GlaxoSmithKline’s pandemic adjuvant have shown positive results. Vaccine efficacy was demonstrated in an environment dominated by SARS-CoV-2 variants, unlike most published Phase III efficacy trials for currently licensed Covid-19 vaccines that were conducted when only the ancestral virus […]